(Q28262507)
Statements
Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results (English)
0 references
20 August 2005
0 references
23
0 references
24
0 references
5474-83
0 references